StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.07−0.32 (-0.93%)

Close on Nov 18, 2026Market cap $2.25BP/E 6.3Yield –

Lakefront Biotherapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -€257.46M. The highest annual figure on record is €3.21B in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€257.46M–
FY2024Dec 31, 2024-€320.03M–
FY2023Dec 31, 2023-€405.97M–
FY2022Dec 31, 2022-€500.54M–
FY2021Dec 31, 2021-€503.83M–
FY2020Dec 31, 2020-€427.34M-113.3%
FY2019Dec 31, 2019€3.21B–
FY2018Dec 31, 2018-€142.47M–
FY2017Dec 31, 2017-€147.03M-161.4%
FY2016Dec 31, 2016€239.40M–
FY2015Dec 31, 2015-€114.59M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?